Therapeutic Vaccines Target Cancer and Other Viral-Induced Diseases

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-11-15-2017
Volume 2017 ebook
Issue 2
Pages: 20-24

The use of therapeutic vaccines presents a new way to manage diseases, such as cancer and sexually transmitted diseases.

As research into harnessing the immune system's natural ability to fight disease advances, so does the development of therapeutic vaccines. Much of the attention in therapeutic vaccine R&D is aimed at targeted therapies for cancer, but substantial research is also going into therapeutic vaccines for other indications, including sexually transmitted diseases.

Download the 

Vaccine Development and Manufacturing 2017 ebook

.

 

 

Article Details

Pharmaceutical Technology and BioPharm International
eBook: Vaccine Development and Manufacturing 2017
November 2017
Pages: 20–24

Citation

When referring to this article, please cite it as F. Mirasol, "Therapeutic Vaccines Target Cancer and Other Viral-Induced Diseases," Pharmaceutical Technology and BioPharm International Vaccine Development and Manufacturing 2017 eBook (November 2017).

Articles in this issue
Therapeutic Vaccines Target Cancer and Other Viral-Induced Diseases
Therapeutic Vaccines Target Cancer and Other Viral-Induced Diseases
Designing and Operating Flexible, High-Containment Vaccine Manufacturing
Designing and Operating Flexible, High-Containment Vaccine Manufacturing
Using Human Challenge Trials to Develop Flu Vaccines
Using Human Challenge Trials to Develop Flu Vaccines
Making Vaccines Accessible
Making Vaccines Accessible
Moving to Closed Systems for Aseptic Processing
Moving to Closed Systems for Aseptic Processing
Cold Chain: Delivering Vaccines to Patients
Cold Chain: Delivering Vaccines to Patients
Accelerating Vaccine Development and Manufacturing
Accelerating Vaccine Development and Manufacturing
Achieving Intensification and Flexibility in Virus Purification with Next-Generation Chromatography Tools
Achieving Intensification and Flexibility in Virus Purification with Next-Generation Chromatography Tools
Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Leroy Hood, MD, PhD
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Incyte, Genesis Therapeutics to Use AI Platform to Discover Small Molecule Compounds

Patrick Lavery
February 21st 2025
Article

The collaboration will utilize Genesis’ proprietary AI platform, initially focusing on targets selected by Incyte.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Google Launches AI Co-Scientist System

Susan Haigney
February 20th 2025
Article

The AI co-scientist is a multi-agent AI system that can work as a virtual scientific collaborator.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

MMS Acquires Exploristics and Its Flagship Modeling and Simulation Platform

Patrick Lavery
February 14th 2025
Article

In seeking a data-driven approach to efficient drug development, MMS aims to enhance its capabilities in advanced clinical trial design, innovative statistics, and data science with the acquisition.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Axplora Announces €50 Million Investment in GLP-1 Manufacturing in France

Patrick Lavery
February 13th 2025
Article

This site was previously the beneficiary of a €7.3 million (US$7.6 million) investment, made in 2022, earmarked for the production of HPAPIs to treat cancer.